Jul 2026· international journal of engineering trends and technology· Vol 74, pp. 269-293· 0 citations
TL;DR
The suggested framework has a high predictive power, robustness, and interpretability, which shows the possibility of using it in the context of precision medicine to diagnose pediatric leukemia.
Abstract
Pediatric Acute Myeloid Leukemia (pAML) is a heterogeneous disease with complicated genomic variants that make it difficult to subclassify the disease properly. The paper suggests a strong and explainable machine learning model applied to the classification of pediatric leukemia subtypes based on high-dimensional data in microarray gene expression. The framework combines ANOVA-based feature selection and variance-based filtering to minimize dimensionality, as well as adaptive SMOTE in order to deal with the imbalance of classes. The strategy of cross-validation is used in a nested way to guarantee the unbiased model evaluation and hyperparameters optimum. Three classifiers, which are Random Forest (RF), Support Vector Machine (SVM), and XGBoost are compared in the terms of weighted F1-score, MCC, and ROC-AUC. The experimental results on the GSE9476 dataset indicate that RF and SVM can be used to obtain perfect classification performance (F1-score = 1.000), whereas XGBoost can be used to obtain competitive results (F1 = 0.919). Statistical significance (p = 0.001) is proven by permutation testing. SHAP-based analysis also determines the biologically significant genes that correlate with the development of leukemia. The suggested framework has a high predictive power, robustness, and interpretability, which shows the possibility of using it in the context of precision medicine to diagnose pediatric leukemia.
The findings demonstrate that integrating statistical feature selection, supervised dimensionality reduction and regularized machine learning can provide highly accurate and interpretable models for leukemia classification, highlighting the growing role of artificial intelligence in precision oncology and public health...
Georgios Vasileiadis· Journal of Biomedical Advanc...· 0 citations
Background
B-acute lymphoblastic leukemia (B-ALL) is a heterogeneous disease comprising more than 20 molecular subtypes defined by distinct gene expression profiles (GEPs) and genetic alterations. Subtypes primarily defined by GEPs remain challenging to identify using conventional cytogenetic and targeted molecular ass...
Seoyoung Lim, Yu Jeong Choi, Yu Jin Park et al.· Annals of Laboratory Medicin...· 0 citations
Acute myeloid leukemia (AML) is a molecularly heterogeneous disease, with considerable variation in molecular abnormalities and gene-expression patterns among patients. This study aimed to identify a compact diagnostic gene signature and develop an interpretable machine-learning model for distinguishing AML from normal...
Shan Liu· Theoretical and Natural Scie...· 0 citations
Background: Breast cancer is the leading cause of cancer-related mortality in females, with 2.3 million new cases diagnosed annually. Machine learning (ML) algorithms have the potential to improve diagnostic accuracy through the analysis of high-dimensional data. However, the lack of standardized benchmarks across diff...
Ali A. Hamad, Naaman Omar· Charmo Journal of Natural Sc...· 0 citations
Breast Cancer (BC) is still one of the deadliest causes of death for women, and timely and precise diagnosis is essential for achieving better clinical results with the use of reliable machine learning-based decision support. All three models, namely the optimized Artificial Neural Network (ANN), Decision Tree (DT) and...
R. Akhtar, Nauman Khalid· International Journal of Inn...· 0 citations
Accurate characterization of tumor subtype is of paramount importance in guiding treatment decisions in pediatric cancers. Here, we present FRANK (Fully-connected RNA-based Augmentation Neural Klassifier), a machine learning approach for classifying pan-cancer pediatric tumors. We curated a set of 11,467 transcriptomes...
K. Sablauskas, T. Kiseļova, L. Bardina et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.